5198-04-9

Basic information

• Product Name: 4-ISOBUTOXY-PHENYLAMINE
• Synonyms: 4-ISOBUTOXY-PHENYLAMINE;AKOS BBB/083;AKOS BC-2573;CHEMBRDG-BB 4017585;AKOS BB325;ASISCHEM Z95330;UKRORGSYN-BB BBV-019169;(4-isobutoxyphenyl)amine(SALTDATA: FREE)
• CAS NO: 5198-04-9
• Molecular Formula: C₁₀H₁₅NO
• Molecular Weight: 165.23
• Mol File: 5198-04-9.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 271.1°C at 760 mmHg
• Flash Point: 117.9°C
• Appearance: /
• Density: 0.997g/cm³
• Vapor Pressure: 0.0066mmHg at 25°C
• Refractive Index: 1.528
• PKA: 5.15±0.10(Predicted)
• CAS DataBase Reference: 4-ISOBUTOXY-PHENYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-ISOBUTOXY-PHENYLAMINE(5198-04-9)
• EPA Substance Registry System: 4-ISOBUTOXY-PHENYLAMINE(5198-04-9)

Safety Data

• Hazard Codes: Xi
• Statements: 43
• Safety Statements: 36/37
• HazardClass: IRRITANT
• Hazardous Substances Data: 5198-04-9(Hazardous Substances Data)

Usage

Description

4-ISOBUTOXY-PHENYLAMINE, also known as 4-isobutoxyaniline, is a chemical compound with the molecular formula C10H15NO. It is a white to light brown solid with a molecular weight of 165.23 g/mol. 4-ISOBUTOXY-PHENYLAMINE is primarily used as an intermediate in the production of pharmaceuticals, dyes, and other organic synthesis. It also serves as a starting material for the synthesis of various organic compounds. Due to its hazardous nature, 4-ISOBUTOXY-PHENYLAMINE can cause skin and eye irritation upon contact and should be handled with care.

Uses

Used in Pharmaceutical Industry:
4-ISOBUTOXY-PHENYLAMINE is used as an intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and medications.
Used in Dye Industry:
In the dye industry, 4-ISOBUTOXY-PHENYLAMINE is utilized as an intermediate for the production of dyes, which are essential for coloring textiles, plastics, and other materials.
Used in Organic Synthesis:
4-ISOBUTOXY-PHENYLAMINE is used as a starting material for the synthesis of various organic compounds, playing a crucial role in the creation of new chemical entities for various applications.

InChI:InChI=1/C10H15NO/c1-8(2)7-12-10-5-3-9(11)4-6-10/h3-6,8H,7,11H2,1-2H3

Upstream product

• 100-02-7 4-nitro-phenol 
• 103-90-2 4-acetaminophenol 
• 1124-31-8 potassium 4-nitrophenolate 
• 100-00-5 4-chlorobenzonitrile 
• 78-77-3 Isobutyl bromide 
• 123-30-8 4-amino-phenol 
• 57027-72-2 1-(2-methylpropoxy)-4-nitrobenzene 
• 26455-37-8 N-[4-(2-methylpropoxy)phenyl]acetamide 

Downstream Products

• 3021-37-2 4-hydroxy phenyl azo-4'-isobutoxy benzene 
• 33284-57-0 N,N'-bis-(4-isobutoxy-phenyl)-thiourea 
• 102759-66-0 N-(4-diethylamino-phenyl)-N'-(4-isobutoxy-phenyl)-thiourea 
• 102321-99-3 N-(4-dimethylamino-phenyl)-N'-(4-isobutoxy-phenyl)-thiourea 
• 88827-78-5 2-(4-Isobutyloxy-anilino)-α-naphthochinon 
• 88618-83-1 2-Brom-3-(4-isobutyloxy-anilino)-α-naphthochinon 

Relevant articles and documents

COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES

The present disclosure relates to compounds according to Formula (I), treating diseases.

A class of 4, 5 - disubstituted imidazole derivatives and its preparation and use (by machine translation)

The invention relates to a compound of general formula I indicated by the 4, 5 - disubstituted imidazole compound, or its pharmaceutically acceptable salt, pharmaceutical composition containing the same and its preparation and use, the compounds can be used as a xanthine oxidase (Xanthine oxidase, XO) inhibitor, used for the treatment of uric acid crystallization at the joints to the deposition of Gout and its complications. (by machine translation)

4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES

The invention provides compounds of the general Formula (I) where R1, R2, and A are defined herein, as well as the preparation, compositions and uses thereof.